First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants with Prostate Cancer

Trial Identifier: D8040C00001
Sponsor: AstraZeneca
Start Date: April 2026
Primary Completion Date: October 2027
Study Completion Date: October 2027
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Darlinghurst, AU, 2010
AU Melbourne, AU, 3000
KR Seoul, KR, 03722
KR Seoul, KR, 06351
US, FL Orlando, FL, US, 32809
US, NJ East Brunswick, NJ, US, 08816
US, NJ Hackensack, NJ, US, 07601
US, RI Providence, RI, US, 02903